U.S. flag

An official website of the United States government

NM_001101.5(ACTB):c.220G>A (p.Gly74Ser) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
May 3, 2016
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000327760.1

Allele description [Variation Report for NM_001101.5(ACTB):c.220G>A (p.Gly74Ser)]

NM_001101.5(ACTB):c.220G>A (p.Gly74Ser)

Gene:
ACTB:actin beta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p22.1
Genomic location:
Preferred name:
NM_001101.5(ACTB):c.220G>A (p.Gly74Ser)
HGVS:
  • NC_000007.14:g.5529304C>T
  • NG_007992.1:g.6298G>A
  • NM_001101.5:c.220G>AMANE SELECT
  • NP_001092.1:p.Gly74Ser
  • LRG_132t1:c.220G>A
  • LRG_132:g.6298G>A
  • LRG_132p1:p.Gly74Ser
  • NC_000007.13:g.5568935C>T
  • NM_001101.3:c.220G>A
Protein change:
G74S
Links:
dbSNP: rs587779770
NCBI 1000 Genomes Browser:
rs587779770
Molecular consequence:
  • NM_001101.5:c.220G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000329919GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Likely pathogenic
(May 3, 2016)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From GeneDx, SCV000329919.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The G74S missense variant in the ACTB gene has been previously published in association with Baraitser-Winter syndrome (DiDonato et al., 2014) and as de novo in the overlapping condition Fryns-Aftimos syndrome (Namiranian et al., 2015), with limited data to fully support pathogenicity. The G74S variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The G74S variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Missense variants in nearby residues (P70L, I75T) have been reported in the Human Gene Mutation Database in association with Baraitser-Winter syndrome (Stenson et al., 2014), supporting the functional importance of this region of the protein. Therefore this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 28, 2024